Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

A. R. Kini, Neil Elliot Kay, L. C. Peterson

Research output: Contribution to journalArticle

184 Citations (Scopus)

Abstract

Recent studies have shown that angiogenesis may be involved in the pathogenesis of hematopoietic malignancies, apart from its well-characterized role in the growth and metastasis of solid tumors. In this study, we quantified the degree of angiogenesis in B cell chronic lymphocytic leukemia (B-CLL) by measuring the microvessel density and hotspot density in bone marrow trephine biopsy sections with B-CLL involvement (n = 12) and compared it to normal bone marrow sections (n = 11). The B-CLL samples had a mean microvessel count/high power field (hpf) of 7.64 while the control samples had a mean microvessel count/hpf of 2.11 (P = 0.0001). The mean hotspot density in the B-CLL sections (14.83/hotspot) was also significantly higher (P = 0.0008) than the mean hotspot density in control bone marrow sections (7.09/hotspot). Both the microvessel density and hotspot density correlated positively with the clinical stage of the B-CLL patients. In a separate cohort of B-CLL patients, the median urine level of the angiogenic peptide, basic fibroblast growth factor (2216.5 pg/g, n = 14), was significantly higher (P = 0.0001) than the bFGF level in normal controls (1084 pg/g, n = 58). These results indicate that angiogenesis may be involved in the pathogenesis of B-CLL.

Original languageEnglish (US)
Pages (from-to)1414-1418
Number of pages5
JournalLeukemia
Volume14
Issue number8
StatePublished - 2000

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Bone Marrow
Microvessels
Angiogenic Proteins
Fibroblast Growth Factor 2
Hematologic Neoplasms
Urine
Neoplasm Metastasis
Biopsy
Growth
Neoplasms

Keywords

  • Angiogenesis
  • Basic fibroblast growth factor
  • Bone marrow
  • Chronic lymphocytic leukemia
  • Microvessel

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. / Kini, A. R.; Kay, Neil Elliot; Peterson, L. C.

In: Leukemia, Vol. 14, No. 8, 2000, p. 1414-1418.

Research output: Contribution to journalArticle

Kini, AR, Kay, NE & Peterson, LC 2000, 'Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia', Leukemia, vol. 14, no. 8, pp. 1414-1418.
Kini, A. R. ; Kay, Neil Elliot ; Peterson, L. C. / Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. In: Leukemia. 2000 ; Vol. 14, No. 8. pp. 1414-1418.
@article{8e851e0c89ba46b89c420675853a217e,
title = "Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia",
abstract = "Recent studies have shown that angiogenesis may be involved in the pathogenesis of hematopoietic malignancies, apart from its well-characterized role in the growth and metastasis of solid tumors. In this study, we quantified the degree of angiogenesis in B cell chronic lymphocytic leukemia (B-CLL) by measuring the microvessel density and hotspot density in bone marrow trephine biopsy sections with B-CLL involvement (n = 12) and compared it to normal bone marrow sections (n = 11). The B-CLL samples had a mean microvessel count/high power field (hpf) of 7.64 while the control samples had a mean microvessel count/hpf of 2.11 (P = 0.0001). The mean hotspot density in the B-CLL sections (14.83/hotspot) was also significantly higher (P = 0.0008) than the mean hotspot density in control bone marrow sections (7.09/hotspot). Both the microvessel density and hotspot density correlated positively with the clinical stage of the B-CLL patients. In a separate cohort of B-CLL patients, the median urine level of the angiogenic peptide, basic fibroblast growth factor (2216.5 pg/g, n = 14), was significantly higher (P = 0.0001) than the bFGF level in normal controls (1084 pg/g, n = 58). These results indicate that angiogenesis may be involved in the pathogenesis of B-CLL.",
keywords = "Angiogenesis, Basic fibroblast growth factor, Bone marrow, Chronic lymphocytic leukemia, Microvessel",
author = "Kini, {A. R.} and Kay, {Neil Elliot} and Peterson, {L. C.}",
year = "2000",
language = "English (US)",
volume = "14",
pages = "1414--1418",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

AU - Kini, A. R.

AU - Kay, Neil Elliot

AU - Peterson, L. C.

PY - 2000

Y1 - 2000

N2 - Recent studies have shown that angiogenesis may be involved in the pathogenesis of hematopoietic malignancies, apart from its well-characterized role in the growth and metastasis of solid tumors. In this study, we quantified the degree of angiogenesis in B cell chronic lymphocytic leukemia (B-CLL) by measuring the microvessel density and hotspot density in bone marrow trephine biopsy sections with B-CLL involvement (n = 12) and compared it to normal bone marrow sections (n = 11). The B-CLL samples had a mean microvessel count/high power field (hpf) of 7.64 while the control samples had a mean microvessel count/hpf of 2.11 (P = 0.0001). The mean hotspot density in the B-CLL sections (14.83/hotspot) was also significantly higher (P = 0.0008) than the mean hotspot density in control bone marrow sections (7.09/hotspot). Both the microvessel density and hotspot density correlated positively with the clinical stage of the B-CLL patients. In a separate cohort of B-CLL patients, the median urine level of the angiogenic peptide, basic fibroblast growth factor (2216.5 pg/g, n = 14), was significantly higher (P = 0.0001) than the bFGF level in normal controls (1084 pg/g, n = 58). These results indicate that angiogenesis may be involved in the pathogenesis of B-CLL.

AB - Recent studies have shown that angiogenesis may be involved in the pathogenesis of hematopoietic malignancies, apart from its well-characterized role in the growth and metastasis of solid tumors. In this study, we quantified the degree of angiogenesis in B cell chronic lymphocytic leukemia (B-CLL) by measuring the microvessel density and hotspot density in bone marrow trephine biopsy sections with B-CLL involvement (n = 12) and compared it to normal bone marrow sections (n = 11). The B-CLL samples had a mean microvessel count/high power field (hpf) of 7.64 while the control samples had a mean microvessel count/hpf of 2.11 (P = 0.0001). The mean hotspot density in the B-CLL sections (14.83/hotspot) was also significantly higher (P = 0.0008) than the mean hotspot density in control bone marrow sections (7.09/hotspot). Both the microvessel density and hotspot density correlated positively with the clinical stage of the B-CLL patients. In a separate cohort of B-CLL patients, the median urine level of the angiogenic peptide, basic fibroblast growth factor (2216.5 pg/g, n = 14), was significantly higher (P = 0.0001) than the bFGF level in normal controls (1084 pg/g, n = 58). These results indicate that angiogenesis may be involved in the pathogenesis of B-CLL.

KW - Angiogenesis

KW - Basic fibroblast growth factor

KW - Bone marrow

KW - Chronic lymphocytic leukemia

KW - Microvessel

UR - http://www.scopus.com/inward/record.url?scp=0033885493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033885493&partnerID=8YFLogxK

M3 - Article

C2 - 10942237

AN - SCOPUS:0033885493

VL - 14

SP - 1414

EP - 1418

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 8

ER -